<?xml version="1.0" encoding="UTF-8"?>
<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#"> 
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> 
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes"/> 
  <meta name="type" content="article"/>
  <meta name="HW.identifier" content="/biorxiv/early/2020/04/12/2020.04.11.037382.1.atom"/>
  <meta name="HW.pisa" content="biorxiv;2020.04.11.037382v2"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2"/>
  <meta name="DC.Identifier" content="10.1101/2020.04.11.037382"/>
  <meta name="DC.Date" content="2020-04-12"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="DC.Rights" content="Â© 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission."/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="SARS-CoV-2 emerged in December 2019 in Wuhan, China and has since infected over 1.5 million people, of which over 100,000 have died. As SARS-CoV-2 spreads across the planet, speculations remain about the evolution of the virus and the range of human cells that can be infected by SARS-CoV-2. In this study, we report the isolation of SARS-CoV-2 from two COVID-19 patients in Toronto, Canada. We determined the genomic sequences of the two isolates and identified single nucleotide changes in representative populations of our virus stocks. More importantly, we have tested a wide range of human immune cells for infectivity with SARS-CoV-2. We confirm from our studies that human primary peripheral blood mononuclear cells (PBMCs) are not permissive to SARS-CoV-2. As SARS-CoV-2 continues to spread globally, it is essential to monitor any small nucleotide polymorphisms in the virus and to continue to isolate circulating strains of the virus to determine cell susceptibility and pathogenicity using in vitro and in vivo infection models. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="DC.Contributor" content="Arinjay Banerjee"/>
  <meta name="DC.Contributor" content="Jalees A. Nasir"/>
  <meta name="DC.Contributor" content="Patrick Budylowski"/>
  <meta name="DC.Contributor" content="Lily Yip"/>
  <meta name="DC.Contributor" content="Patryk Aftanas"/>
  <meta name="DC.Contributor" content="Natasha Christie"/>
  <meta name="DC.Contributor" content="Ayoob Ghalami"/>
  <meta name="DC.Contributor" content="Kaushal Baid"/>
  <meta name="DC.Contributor" content="Amogelang R. Raphenya"/>
  <meta name="DC.Contributor" content="Jeremy A Hirota"/>
  <meta name="DC.Contributor" content="Matthew S. Miller"/>
  <meta name="DC.Contributor" content="Allison J McGeer"/>
  <meta name="DC.Contributor" content="Mario A Ostrowski"/>
  <meta name="DC.Contributor" content="Robert A. Kozak"/>
  <meta name="DC.Contributor" content="Andrew G McArthur"/>
  <meta name="DC.Contributor" content="Karen Mossman"/>
  <meta name="DC.Contributor" content="Samira Mubareka"/>
  <meta name="article:published_time" content="2020-04-12"/>
  <meta name="article:section" content="New Results"/>
  <meta name="citation_title" content="Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2"/>
  <meta name="citation_abstract" lang="en" content="&lt;;p&gt;;SARS-CoV-2 emerged in December 2019 in Wuhan, China and has since infected over 1.5 million people, of which over 100,000 have died. As SARS-CoV-2 spreads across the planet, speculations remain about the evolution of the virus and the range of human cells that can be infected by SARS-CoV-2. In this study, we report the isolation of SARS-CoV-2 from two COVID-19 patients in Toronto, Canada. We determined the genomic sequences of the two isolates and identified single nucleotide changes in representative populations of our virus stocks. More importantly, we have tested a wide range of human immune cells for infectivity with SARS-CoV-2. We confirm from our studies that human primary peripheral blood mononuclear cells (PBMCs) are not permissive to SARS-CoV-2. As SARS-CoV-2 continues to spread globally, it is essential to monitor any small nucleotide polymorphisms in the virus and to continue to isolate circulating strains of the virus to determine cell susceptibility and pathogenicity using in vitro and in vivo infection models.&lt;;/p&gt;;"/>
  <meta name="citation_journal_title" content="bioRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="citation_publication_date" content="2020/01/01"/>
  <meta name="citation_mjid" content="biorxiv;2020.04.11.037382v2"/>
  <meta name="citation_id" content="2020.04.11.037382v2"/>
  <meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.04.11.037382v2"/>
  <meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.11.037382v2.abstract"/>
  <meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.04.11.037382v2.full"/>
  <meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/04/12/2020.04.11.037382.1.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2020.04.11.037382"/>
  <meta name="citation_section" content="New Results"/>
  <meta name="citation_firstpage" content="2020.04.11.037382"/>
  <meta name="citation_author" content="Arinjay Banerjee"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="banera9@mcmaster.ca"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0002-2821-8357"/>
  <meta name="citation_author" content="Jalees A. Nasir"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="nasirja@mcmaster.ca"/>
  <meta name="citation_author" content="Patrick Budylowski"/>
  <meta name="citation_author_institution" content="University of Toronto;"/>
  <meta name="citation_author_email" content="patrick.budylowski@mail.utoronto.ca"/>
  <meta name="citation_author" content="Lily Yip"/>
  <meta name="citation_author_institution" content="Sunnybrook Research Institute"/>
  <meta name="citation_author_email" content="lily.yip@sunnybrook.ca"/>
  <meta name="citation_author" content="Patryk Aftanas"/>
  <meta name="citation_author_institution" content="Sunnybrook Research Institute"/>
  <meta name="citation_author_email" content="patryk.aftanas@sri.utoronto.ca"/>
  <meta name="citation_author" content="Natasha Christie"/>
  <meta name="citation_author_institution" content="University of Toronto;"/>
  <meta name="citation_author_email" content="natasha.christie@utoronto.ca"/>
  <meta name="citation_author" content="Ayoob Ghalami"/>
  <meta name="citation_author_institution" content="University of Toronto;"/>
  <meta name="citation_author_email" content="ayoob.ghalami@utoronto.ca"/>
  <meta name="citation_author" content="Kaushal Baid"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="baidk@mcmaster.ca"/>
  <meta name="citation_author" content="Amogelang R. Raphenya"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="raphenar@mcmaster.ca"/>
  <meta name="citation_author" content="Jeremy A Hirota"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="hirotaja@mcmaster.ca"/>
  <meta name="citation_author" content="Matthew S. Miller"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="mmiller@mcmaster.ca"/>
  <meta name="citation_author" content="Allison J McGeer"/>
  <meta name="citation_author_institution" content="University of Toronto;"/>
  <meta name="citation_author_email" content="allison.mcgeer@sinaihealthsystem.ca"/>
  <meta name="citation_author" content="Mario A Ostrowski"/>
  <meta name="citation_author_institution" content="University of Toronto;"/>
  <meta name="citation_author_email" content="mario.ostrowski@gmail.com"/>
  <meta name="citation_author" content="Robert A. Kozak"/>
  <meta name="citation_author_institution" content="Sunnybrook Research Institute"/>
  <meta name="citation_author_email" content="rob.kozak@sunnybrook.ca"/>
  <meta name="citation_author" content="Andrew G McArthur"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="mcarthua@mcmaster.ca"/>
  <meta name="citation_author" content="Karen Mossman"/>
  <meta name="citation_author_institution" content="McMaster University;"/>
  <meta name="citation_author_email" content="mossk@mcmaster.ca"/>
  <meta name="citation_author" content="Samira Mubareka"/>
  <meta name="citation_author_institution" content="University of Toronto;"/>
  <meta name="citation_author_email" content="samira.mubareka@sunnybrook.ca"/>
  <meta name="twitter:title" content="Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2"/>
  <meta name="twitter:site" content="@biorxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="twitter:description" content="SARS-CoV-2 emerged in December 2019 in Wuhan, China and has since infected over 1.5 million people, of which over 100,000 have died. As SARS-CoV-2 spreads across the planet, speculations remain about the evolution of the virus and the range of human cells that can be infected by SARS-CoV-2. In this study, we report the isolation of SARS-CoV-2 from two COVID-19 patients in Toronto, Canada. We determined the genomic sequences of the two isolates and identified single nucleotide changes in representative populations of our virus stocks. More importantly, we have tested a wide range of human immune cells for infectivity with SARS-CoV-2. We confirm from our studies that human primary peripheral blood mononuclear cells (PBMCs) are not permissive to SARS-CoV-2. As SARS-CoV-2 continues to spread globally, it is essential to monitor any small nucleotide polymorphisms in the virus and to continue to isolate circulating strains of the virus to determine cell susceptibility and pathogenicity using in vitro and in vivo infection models. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="og-title" property="og:title" content="Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2"/>
  <meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.04.11.037382v2"/>
  <meta name="og-site-name" property="og:site_name" content="bioRxiv"/>
  <meta name="og-description" property="og:description" content="SARS-CoV-2 emerged in December 2019 in Wuhan, China and has since infected over 1.5 million people, of which over 100,000 have died. As SARS-CoV-2 spreads across the planet, speculations remain about the evolution of the virus and the range of human cells that can be infected by SARS-CoV-2. In this study, we report the isolation of SARS-CoV-2 from two COVID-19 patients in Toronto, Canada. We determined the genomic sequences of the two isolates and identified single nucleotide changes in representative populations of our virus stocks. More importantly, we have tested a wide range of human immune cells for infectivity with SARS-CoV-2. We confirm from our studies that human primary peripheral blood mononuclear cells (PBMCs) are not permissive to SARS-CoV-2. As SARS-CoV-2 continues to spread globally, it is essential to monitor any small nucleotide polymorphisms in the virus and to continue to isolate circulating strains of the virus to determine cell susceptibility and pathogenicity using in vitro and in vivo infection models. ### Competing Interest Statement The authors have declared no competing interest."/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="citation_date" content="2020-04-12"/> 
  <meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/> 
  <title>Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2 | bioRxiv</title> 
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-1242359 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-category-new-results"> 
  <div class="article abstract-view ">
   <span class="highwire-journal-article-marker-start"/>
   <div class="section abstract" id="abstract-1">
    <h2>Abstract</h2>
    <p id="p-2">SARS-CoV-2 emerged in December 2019 in Wuhan, China and has since infected over 1.5 million people, of which over 100,000 have died. As SARS-CoV-2 spreads across the planet, speculations remain about the evolution of the virus and the range of human cells that can be infected by SARS-CoV-2. In this study, we report the isolation of SARS-CoV-2 from two COVID-19 patients in Toronto, Canada. We determined the genomic sequences of the two isolates and identified single nucleotide changes in representative populations of our virus stocks. More importantly, we have tested a wide range of human immune cells for infectivity with SARS-CoV-2. We confirm from our studies that human primary peripheral blood mononuclear cells (PBMCs) are not permissive to SARS-CoV-2. As SARS-CoV-2 continues to spread globally, it is essential to monitor any small nucleotide polymorphisms in the virus and to continue to isolate circulating strains of the virus to determine cell susceptibility and pathogenicity using in vitro and in vivo infection models.</p>
   </div>
   <h3>Competing Interest Statement</h3>
   <p id="p-3">The authors have declared no competing interest.</p>
   <div class="section fn-group" id="fn-group-1">
    <h2>Footnotes</h2>
    <ul>
     <li class="fn-update fn-group-summary-of-updates" id="fn-1">
      <p id="p-4">Discussion has been expanded and minor typos have been addressed. The title has been shortened.</p>
     </li>
    </ul>
   </div>
   <span class="highwire-journal-article-marker-end"/>
  </div>
 </body>
</html>
